Colombia promotes itself as a destination for clinical research

The goal is to position the country as the top destination in Latin America to conduct clinical research for the biopharma and medical device industry.

Miami, FL, May 30, 2015 ΓÇô Procolombia, ColombiaΓÇÖs exports, tourism, investment, and country brand agency, signed an alliance in 2014 with Interventional Concepts, Inc. (ICI) ΓÇöa leading clinical development firm in Miami, FL. ICI focuses in operationalizing clinical trials in Colombia for innovative MedTech startups and will collaborate with Procolombia to position Colombia as the premier destination to conduct clinical trials for innovative medical technologies and biopharma companies around the world.

Colombia, strategically located close to the US and on the same EST time zone, offers many strengths for clinical trials. It is the third-most populous country in Latin America, after Mexico and Brazil, and itΓÇÖs considered the most urbanized Latin American nation. Nearly 89% of its 50 million people live in big cities; it has Good Clinical Practice guidance and over 120 sites certified to run trials. It has a centralized healthcare system that draws patients with particular needs to specialized or regional hospitals, which can help speed patient recruitment. A large number of experienced investigators working in certified sites means fewer concerns about generating high-quality data. Also, treatment-naive populations are plentiful. Strong doctor-patient relationships support high trial recruitment rates and low dropout rates. Furthermore, prices for hospital procedures in Colombia are considered to be much lower than costs in the US and Europe.


See more.


Get in touch

Cr 37a # 8 - 43, Edif. Rose Street Ofic. 901, Medellin, Colombia, 050010
15 Maple Ave, Paoli, USA, PA 19301

PHONE +1(610)616-3922